A Retrospective Analysis of the Real-Life Utilization of Ranibizumab in Patients with Wet Age-Related Macular Degeneration from Portugal

INTRODUCTION: Anti-vascular endothelial growth factor therapy has revolutionized the treatment of wet age-related macular degeneration; however, it is important to monitor actual use of ranibizumab and related treatment outcomes in routine practice. MATERIAL AND METHODS: This was a retrospective, ob...

ver descrição completa

Detalhes bibliográficos
Autor principal: Silva, R (author)
Outros Autores: Goncalves, C (author), Meireles, A (author), Teixeira, C (author), Rosa, P (author), Monteiro-Grillo, M (author), Canelas, J (author), Carneiro, A (author), Flores, R (author)
Formato: article
Idioma:eng
Publicado em: 2017
Assuntos:
CHLC OFT
Portugal
Angiogenesis Inhibitors/therapeutic use
Ranibizumab/therapeutic use
Retrospective Studies
Wet Macular Degeneration/drug therapy
Texto completo:http://hdl.handle.net/10400.17/2751
País:Portugal
Oai:oai:repositorio.chlc.min-saude.pt:10400.17/2751

Texto Completo

http://hdl.handle.net/10400.17/2751

Registos relacionados